| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |